The medical treatment landscape depends heavily on the sales of ablation devices since these devices offer state-of-the-art solutions for a variety of therapeutic applications. Ablation techniques that are precise and minimally invasive are still being utilised more frequently to treat conditions including heart arrhythmias and some cancers. By 2023, it is projected that the global …
Category Archives: Healthcare Trends
Preterm Birth Prevention and Management Market Envisions Strong Growth with a Resilient 10.1% CAGR from 2022 to 2029-FMI Projection
The preterm birth prevention and management market, which is at the forefront of maternal healthcare, is focused on finding ways to enhance prenatal outcomes. The market strongly emphasises preventive approaches and advanced treatment options to address the myriad complications associated with premature births. Ongoing research and innovative approaches show the commitment to reducing the number …
Canine Atopic Dermatitis Treatment Market Poised for Remarkable 12.3% CAGR Expansion from 2022 to 2029-FMI Projection
Treatments for canine atopic dermatitis are predicted to reach a market value of about US$ 2.37 billion by the end of 2029. As more attention is focused on developing novel treatments, like monoclonal antibodies, to treat atopic dermatitis in dogs and cats, the market is anticipated to expand. The market for treatments for canine atopic …
Veterinary Biologics Market Envisions a Pinnacle of US$ 18.2 Billion by 2029-FMI Projection
According to a recent market report by Future Market Insights (FMI), the global veterinary biologics market is expected to be valued US$ 18.2 billion by 2029 and US$ 11.4 billion in 2022. Rising trend of pet ownership across the world has increased concerns related to pet health, resulting in rising demand for veterinary biologics. According …
Dosimetry Market on Track to Shine with a Valuation of US$ 4.3 Billion by 2029-FMI Projection
According to a recent Future Industry Insights (FMI) report, the dosimetry market would generate revenues exceeding US$ 4.3 billion by 2029 as a result of growing adoption at different healthcare facilities. Strict government regulations regarding radiation toxicity levels, growing awareness about the harmful effect of radiation, and rising concerns about the health of employees working …
Counterfeit Drug Detection Device Market Gears up to Reach US$ 1.56 Billion by 2029-FMI Projection
The counterfeit drug detecting devices market sales is anticipated to grow rapidly at a compound annual growth rate (CAGR) of 4.0% between 2022 and 2029, reaching a valuation of around US$ 1.14 billion in 2022. According to Future Market Insights forecasts, counterfeit chemical composition detection devices will represent a significant portion of the market in …
Lung Cancer Surgery Market Envisions Reaching a Resounding US$ 1.98 Billion by 2029-FMI Projection
According to a new market report by Future Market Insights (FMI), the global lung cancer surgery market sales is expected to reach US$ 1.98 billion by 2029 from its anticipated US$ 1.23 billion in 2021. Robotic thoracic surgery would continue to be preferred over traditional surgical techniques because it provides greater magnification, greater precision, and …
Global Orthopedic Prosthetic Devices Industry is projected to demonstrate a 4.7% CAGR, with projections reaching 2032 | FMI
The global orthopedic prosthetic devices industry is poised for a monumental surge over the next decade, projecting a remarkable Compound Annual Growth Rate (CAGR) of 4.7% between 2022 and 2032. This forecast signals a pivotal era of innovation and heightened accessibility to groundbreaking solutions, aimed at empowering individuals affected by serious accidents, congenital conditions, or …
Global Artificial Pancreas Device Systems Industry is poised to witness a noteworthy 18.2% CAGR by 2032, as per FMI’s analysis
The global artificial pancreas device systems industry is on the brink of a transformative period, poised for an unprecedented growth trajectory. Projections indicate a staggering Compound Annual Growth Rate (CAGR) of 18.2%, steering the industry towards remarkable expansion up to 2032. The artificial pancreas device systems industry is set to redefine the landscape of diabetes …
Global Extended Release Drugs Industry is projected to achieve an 11% CAGR by 2032, with a central emphasis on improving medication adherence, as per FMI
Over the projection period of 2022 to 2032, sales in the global extended release drugs industry demand are anticipated to grow at a CAGR of 11%. The market for extended-release medications is currently worth US$ 48 billion. Demand for extended-release medications is predicted to increase in the upcoming years as a result of altered prescription …